Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

NRX101 for Moderate Bipolar Depression and Suicidal Ideation (MBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03395392
Recruitment Status : Not yet recruiting
First Posted : January 10, 2018
Last Update Posted : October 30, 2020
Sponsor:
Collaborators:
Target Health Inc.
Bracket, Inc.
Statistics Collaborative, Inc.
Information provided by (Responsible Party):
NeuroRx, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 31, 2022
Estimated Study Completion Date : March 31, 2022